Louisbourg Investments »

Crispr Therapeutics shares owned by Louisbourg Investments

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Louisbourg Investments from 13F filings

Historical chart of Louisbourg Investments investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Louisbourg Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Louisbourg Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9k 60 64.82
2025-06-30 $2.9k 60 48.63

More positions owned by Louisbourg Investments

Canadian Natl Ry (CNI)
Shopify Inc cl a (SHOP)
Microsoft Corporation (MSFT)
Wheaton Precious Metals Corp (WPM)
iShares S&P 500 Index (IVV)
Osisko Gold Royalties (OR)
Gildan Activewear Inc Com Cad (GIL)
Rogers Communications -cl B (RCI)
Alphabet Inc Class C cs (GOOG)
Taiwan Semiconductor Mfg (TSM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Lightspeed Comme (LSPD)
Colliers International Group sub vtg (CIGI)

View all positions for Louisbourg Investments

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics